Champions Oncology Inc Cash Flow Conversion Efficiency
Champions Oncology Inc cash flow conversion efficiency. Based on the latest financial reports, Champions Oncology Inc (CSBR) has a cash flow conversion efficiency ratio of -0.306x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.34 Million) by net assets ($4.38 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Champions Oncology Inc (1996–2025)
Cash flow conversion efficiency of Champions Oncology Inc from 1996 to 2025. This chart illustrates how Champions Oncology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Champions Oncology Inc (CSBR) stock price for real-time trading data and today's change.
Champions Oncology Inc Cash Flow Conversion Ratio Explained
Champions Oncology Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Champions Oncology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Champions Oncology Inc ranked by their cash flow conversion efficiency. Also see Champions Oncology Inc market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
0.065x |
|
Penta Teknoloji Urunleri Dagitim Ticaret AS
IS:PENTA
|
0.008x |
|
Harboes Bryggeri A/S
CO:HARB-B
|
0.029x |
|
Thai Wah Public Company Limited
BK:TWPC
|
-0.001x |
|
Huang Long Development Co Ltd
TWO:3512
|
0.102x |
|
Coffee Day Enterprises Limited
NSE:COFFEEDAY
|
0.025x |
|
Future Vision II Acquisition Corporation Ordinary shares
NASDAQ:FVN
|
0.563x |
|
Taekyung BK Co Ltd
KO:014580
|
0.037x |
Annual Cash Flow Conversion Efficiency for Champions Oncology Inc (1996–2025)
The table below shows the annual cash flow conversion efficiency of Champions Oncology Inc from 1996 to 2025. Review CSBR FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $3.77 Million | $7.39 Million | 1.958x | -39.28% |
| 2024-04-30 | $-1.90 Million | $-6.14 Million | 3.225x | +278.02% |
| 2023-04-30 | $4.64 Million | $3.96 Million | 0.853x | +19.44% |
| 2022-04-30 | $9.10 Million | $6.50 Million | 0.714x | +415.62% |
| 2021-04-30 | $7.43 Million | $-1.68 Million | -0.226x | -139.72% |
| 2020-04-30 | $5.10 Million | $2.90 Million | 0.570x | -31.52% |
| 2019-04-30 | $2.24 Million | $1.86 Million | 0.832x | -98.30% |
| 2018-04-30 | $-25.00K | $-1.23 Million | 49.040x | +790.70% |
| 2017-04-30 | $400.00K | $-2.84 Million | -7.100x | +73.81% |
| 2016-04-30 | $238.00K | $-6.45 Million | -27.109x | -2168.67% |
| 2015-04-30 | $8.06 Million | $-9.63 Million | -1.195x | -11.28% |
| 2014-04-30 | $3.20 Million | $-3.43 Million | -1.074x | -91.58% |
| 2013-04-30 | $7.60 Million | $-4.26 Million | -0.560x | -156.60% |
| 2012-04-30 | $-5.28 Million | $-5.23 Million | 0.990x | +134.85% |
| 2011-04-30 | $19.00K | $-54.00K | -2.842x | -113.43% |
| 2010-04-30 | $1.58 Million | $-2.10 Million | -1.332x | -187.32% |
| 2009-04-30 | $1.92 Million | $-888.00K | -0.463x | -312.75% |
| 2008-04-30 | $3.64 Million | $792.40K | 0.218x | -27.53% |
| 2007-04-30 | $-261.06K | $-78.47K | 0.301x | +114.48% |
| 2006-04-30 | $-670.51K | $-93.97K | 0.140x | +44.39% |
| 2005-04-30 | $-366.80K | $-35.60K | 0.097x | -87.51% |
| 2004-04-30 | $-92.70K | $-72.05K | 0.777x | -34.29% |
| 2003-04-30 | $-209.75K | $-248.12K | 1.183x | -81.89% |
| 2002-04-30 | $-5.00K | $-32.68K | 6.530x | +581.82% |
| 2001-04-30 | $151.06K | $144.68K | 0.958x | +4754.15% |
| 2000-04-30 | $891.69K | $-18.35K | -0.021x | -116.65% |
| 1999-04-30 | $890.00K | $110.00K | 0.124x | -72.34% |
| 1998-04-30 | $940.00K | $420.00K | 0.447x | +164.02% |
| 1997-04-30 | $650.00K | $110.00K | 0.169x | +342.56% |
| 1996-04-30 | $430.00K | $-30.00K | -0.070x | -- |
About Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform … Read more